Skip to content

Peptide fragment assay for prohormone P7 (e.g., proinsulin or related precursor peptides)

Published: August 9, 2026Updated: August 16, 2026

This test measures small peptide fragments derived from prohormones, such as those found in proinsulin or similar proteins. It may be used to assess metabolic or endocrine function, though specific clinical indications vary.

Quick summary

["This test helps evaluate how your body processes certain hormones or proteins over time."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
25580-2
Short code
C peptide sp7 p chal SerPl-sCnc
Synonyms
C peptide sp7 p chal SerPl-sCnc
Category
coagulation
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Ref low
0.8
Ref high
1.2
Critical range
— – 5 N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
85610
SNOMED
396252006
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms or conditions linked to abnormal hormone processing, such as diabetes, metabolic disorders, or suspected prohormone dysfunction. It could also be part of a broader evaluation for endocrine or metabolic screening.

What to Expect Before the Test

No special preparation is typically required, but you may be asked to fast for a certain period if the test involves a blood draw. Follow your provider’s instructions carefully to ensure accurate results.

What the Test Involves

A blood sample is collected, usually from a vein in your arm. The sample is processed to measure peptide fragments in the serum or plasma. The test uses advanced laboratory techniques to detect these fragments at very low concentrations.

What the Results Mean

Results may indicate whether your body is producing or processing these peptide fragments normally. Elevated or altered levels could suggest metabolic or endocrine issues, but interpretation depends on clinical context and other test results.

Reference range

INR: 0.8-1.2 (warfarin: 2.0-3.0)N/A

Specimen: serum

Inform your healthcare provider if you are taking blood thinners. No special preparation required.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

P7 Peptide Screening

Frequently asked questions

What could cause abnormal results?
Abnormal results may be associated with conditions affecting hormone metabolism, such as diabetes (e.g., proinsulin-related disorders), endocrine tumors, or genetic metabolic disorders. However, individual results must be evaluated alongside patient history and other diagnostic findings.
How often should this test be repeated?
Repetition depends on your clinical situation. Your healthcare provider will determine if follow-up testing is needed based on initial results and ongoing symptoms.
Can this test be done at home?
No, this test requires a laboratory setting. Blood samples are collected by a healthcare professional, and results are processed in a clinical lab.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy